Abstract:Previous studies have shown that high glucose stimulates renal SREBP-1 gene expression and increases renal tubular cells lipid metabolism, however, the mechanisms remain elusive. In the present study we demonstrated that PI3K/Akt pathway was activated in human renal proximal tubular cell line (HKC) exposed to high glucose accompanied with up-regulation of SREBP-1, TGF-β1, lipid droplets deposits and extracellular matrix production. Inhibition of PI3K/Akt pathway by chemical LY294002 or specific short hairpin R… Show more
“…Effects of inhibiting PI3K-Akt-mTOR pathway on de novo lipid synthesis Lipid biosynthesis is essential for the maintenance of cellular homeostasis. Accumulating evidence supports the idea that PI3K-Akt-mTOR pathway stimulates the lipid synthesis via inducing the expression of SREBP, which activates the transcription of the genes FAS and ACC, the two key enzymes of fatty acid biosynthesis (Laplante and Sabatini, 2010;Hao et al, 2011). Our previous studies demonstrated that overfeeding-induced elevated hepatic lipogenesis, accompanied with up-regulation of gene expression associating with de novo lipid synthesis, which was the main cause of fatty liver formation in goose (Han et al, 2008).…”
Phosphatidylinositol-3 kinases (PI3K)-Protein kinase B (Akt)-mammalian target of rapamycin (mTOR) pathway plays an important role in the synthesis and secretion of triacylglycerol. However, the mechanism of PI3K-Akt-mTOR pathway in regulating lipid metabolism of goose liver was poorly understood. The purpose of this study was to determine how PI3K-Akt-mTOR pathway regulating lipid metabolic homeostasis in goose hepatocytes. Goose primary hepatocytes were treated with different PI3K-Akt-mTOR signal inhibitors (LY294002, rapamycin and NVP-BEZ235) for 24 h. The results showed that these inhibitors evidently inhibited PI3K-Akt-mTOR downstream signaling. Meanwhile, these PI3K-Akt-mTOR inhibitors reduced intracellular lipid accumulation, decreased the mRNA expression and protein content of genes involved in the de novo fatty acid synthesis, while increased the transcriptional and protein level of key factors involved in fatty acid oxidation and very low density lipoprotein (VLDL) assembly and secretion. Conclusion: These findings suggested that the reduction of lipids accumulation induced-by inhibiting PI3K-Akt-mTOR pathway was closely linked to the decrease of lipogenesis, the increase of fatty acids oxidation, and the increase of VLDL assembly and secretion in goose hepatocytes.
“…Effects of inhibiting PI3K-Akt-mTOR pathway on de novo lipid synthesis Lipid biosynthesis is essential for the maintenance of cellular homeostasis. Accumulating evidence supports the idea that PI3K-Akt-mTOR pathway stimulates the lipid synthesis via inducing the expression of SREBP, which activates the transcription of the genes FAS and ACC, the two key enzymes of fatty acid biosynthesis (Laplante and Sabatini, 2010;Hao et al, 2011). Our previous studies demonstrated that overfeeding-induced elevated hepatic lipogenesis, accompanied with up-regulation of gene expression associating with de novo lipid synthesis, which was the main cause of fatty liver formation in goose (Han et al, 2008).…”
Phosphatidylinositol-3 kinases (PI3K)-Protein kinase B (Akt)-mammalian target of rapamycin (mTOR) pathway plays an important role in the synthesis and secretion of triacylglycerol. However, the mechanism of PI3K-Akt-mTOR pathway in regulating lipid metabolism of goose liver was poorly understood. The purpose of this study was to determine how PI3K-Akt-mTOR pathway regulating lipid metabolic homeostasis in goose hepatocytes. Goose primary hepatocytes were treated with different PI3K-Akt-mTOR signal inhibitors (LY294002, rapamycin and NVP-BEZ235) for 24 h. The results showed that these inhibitors evidently inhibited PI3K-Akt-mTOR downstream signaling. Meanwhile, these PI3K-Akt-mTOR inhibitors reduced intracellular lipid accumulation, decreased the mRNA expression and protein content of genes involved in the de novo fatty acid synthesis, while increased the transcriptional and protein level of key factors involved in fatty acid oxidation and very low density lipoprotein (VLDL) assembly and secretion. Conclusion: These findings suggested that the reduction of lipids accumulation induced-by inhibiting PI3K-Akt-mTOR pathway was closely linked to the decrease of lipogenesis, the increase of fatty acids oxidation, and the increase of VLDL assembly and secretion in goose hepatocytes.
“…In cultured renal tubular cells, high-glucose media could induce expression of SREBP-1 mRNA and protein levels, resulting in an enhanced cellular TG content through induction of FAS and ACC [22,49] . The relationship between SREBP-1 and an activated PI3K/Akt pathway has been confirmed in diabetic rats and in in vitro-cultured HKC cells [50] . Recently, mTOR was revealed to be involved in diabetic renal lipogenesis and could be a potential target for the treatment of DKD through regulation of SREBP-1 [51] .…”
Section: Srebp-1 Serves As a Mediator For The Crosstalk Between Glucomentioning
Background: Diabetic kidney disease (DKD) is defined by the functional, structural, and clinical abnormalities of the kidney that are caused by diabetes. Summary: One-third of both type 1 diabetes and type 2 diabetes patients suffer from DKD, which is the leading cause of end-stage renal disease, and is also associated with cardiovascular disease and high public health care costs. Serum glucose level and lipid level are key factors in the pathogenesis of DKD and are modifiable. The goal of this review is to provide an update on the roles of glucose and lipid metabolism in DKD and their crosstalk at the molecular level. We will further discuss the recent advances regarding metabolic nuclear receptors in glucose-lipid crosstalk, which may provide new potential therapeutic targets for DKD. Key Message: AMPK, SREBP-1, and some metabolic hormone receptors including liver X receptors, farnesoid X receptors, and peroxisome proliferator-activated receptors mediate the crosstalk of hyperglycemia and dyslipidemia in diabetic kidney disease and might be potential treatment candidates.
“…The molecular mechanism of the SB202190-mediated increases in SREBP-1 and FAS expression, and the involvement of p38 in TNF-a induced lipogenensis in sebocytes, remain to be solved. PI3K/Akt cell signaling is one of the key regulatory pathways for lipogensis in various cells including renal cells, prostate cells, hepatocytes, and adipocytes [30,[32][33][34], as well as in human sebocytes stimulated by insulin-like growth factor-1 [19]. During lipid synthesis, PI3K/ Akt regulates not only SREBP-1 activities at the transcriptional level [35] but also SREBP-1 cleavage activating protein (SCAP) activities [36]; the latter is a SREBP cleavage enzyme, whose activity leads to the maturation and translocation of SREBP-1.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.